Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

참고문헌 (9)

1. Stewart EL, "Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review", Transl Lung Cancer Res, 4, pp.67~81 (2015)
2. Choi CM, "Mechanisms of acquired resistance to epidermal growth factor receptor inhibitors and overcoming strategies in lung cancer", J Lung Cancer, 11, pp.59~65 (2012)
3. Yu HA, "Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers", Clin Cancer Res, 19, pp.2240~2247 (2013)
4. Jukna A, "Squamous cell carcinoma “transformation” concurrent with secondary T790M mutation in resistant EGFR-mutated adenocarcinomas", J Thorac Oncol, 11, pp.e49~e51 (2016)
5. Kuiper JL, "Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor", J Clin Pathol, 68, pp.320~321 (2015)
6. Levin PA, "Histologic transformation from adenocarcinoma to squamous cell carcinoma as a mechanism of resistance to EGFR inhibition", J Thorac Oncol, 10, pp.e86~e88 (2015)
7. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
8. Cagle PT, "Advances in treatment of lung cancer with targeted therapy.", Arch Pathol Lab Med, 136, pp.504~509 (2012)
9. 안수민, "Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases", Journal of Pathology and Translational Medicine, 50(4), pp.258~263 (2016), 대한병리학회[DOI]

관련 논문AI추천